Search Results - peptide

2 Results

Sort By:

Targeting Prostate Cancer with a Novel T-Cell Receptor and Tissue-Specific Cancer Antigens for Improved Immune Response (UCLA Case No. 2022-070)

Researchers from UCLA’s Department of Microbiology, Immunology, & Molecular Genetics (MIMG), and the department of Molecular and Medical Pharmacology have identified a set of tissue-specific antigens which have been used to isolate and characterize a group of novel T-cell receptors (TCRs) which target prostate cancer specifically. Furthermore,...

Published: 2/26/2024 | Inventor(s): Owen Witte, Zhiyuan Mao, Jami Witte, Pavlo Nesterenko, John Lee

Keywords(s): Cancer, cancer antigen, Peptide, peptides, prostate cancer, protein, t-cells

Category(s): Therapeutics, Therapeutics > Oncology > Oncology Immunotherapy, Therapeutics > Oncology, Therapeutics > Immunology And Immunotherapy

2020-439 4F FOR AMD

Researchers at UCLA’s David Geffen School of Medicine, in collaboration with researchers from the University of Lubeck, Germany, have developed an anti-inflammatory, antiatherogenic peptide which ameliorates symptoms and progression of age-related macular degeneration (AMD) and could work to reduce the severity of other eye diseases presenting...

Published: 7/19/2023 | Inventor(s): Alan Fogelman, Mohamad Navab, Gattadahalli Anantharamaiah, Martin Rudolf

Keywords(s): Macular Degeneration, Peptide

Category(s): Platforms > Drug Delivery > Peptide Base